The life sciences and biotechnology industry is experiencing rapid growth and advancements, and the future looks incredibly promising. With a focus on finding solutions to some of the world’s most pressing problems, this field is poised for exciting developments and breakthroughs in the coming years. Here, we’ll explore some of the key areas where we can expect to see growth in the future of life sciences and biotechnology. Personalized Medicine: The rise of genomics and the increasing availability of genetic data are driving the development of personalized medicine. Researchers are using this information to create therapies and treatments tailored to an individual’s specific needs, resulting in improved outcomes and reduced side effects. Regenerative Medicine : The development of stem cell therapies is enabling scientists to promote the growth of new cells and tissues, which can be used to repair damage caused by injury or disease. Regenerative medicine has the potential to play ...
Two important standards are supported by CDISC : SDTM (Study Data Tabulation Model) and ADaM. (Analysis Data Model). Although the adoption of CDISC standards may increase development costs, you can reduce those costs by choosing the appropriate technology and implementation strategy. SDTM and ADaM datasets in the adoption of CDISC standards not only simplifies procedures but also stimulates innovation, efficiency, betters data quality, reduces costs, and boosts predictability. In comparison to SDTM and SEND, CDISC’s Analysis Data Model (ADaM) is a little different. Although the model is less prescriptive, it still comprises a core model and an implementation guide. Within specific limitations established by the model, more variables may be added. This provides a level of standardization that enables it to be easily understood by reviewers, while giving it the flexibility to be used for any type of study. This article was originally taken from PointCross: SDTM - All ...